www
.diabetesnet
.com
|
 |
Diabetes and Health News
For week of 12/26/98

MiniMed Plans For February
Meeting With The FDA
MiniMed says the Food and Drug Administration
(FDA) will review its premarket approval application (PMA) for its continuous
glucose monitoring system on February 26, 1999. Its minimally invasive
continuous glucose monitoring system measures interstitial glucose levels
and is designed to be inserted into the subcutaneous tissue, usually in
the abdominal area, utilizing a soft cannula type device. MiniMed's first
product will be a monitor to be used by physicians as a diagnostic tool
in treating patients with diabetes, much like current cardiac holter-style
devices. If the FDA grants approval of the PMA, MiniMed plans later to
market a testing device for use by consumers. You can also read CEO Al
Mann's promotional comments given to The
Wall Street Transcript.
Encelle Receives Research
Funding For Beta Cell Transplants
A small biotech company, Encelle, has
raised $5 million to expand testing of beta cell transplants for diabetes,
eliminating the need for insulin shots. Encelle Inc.'s bioartificial pancreas
has functioned successfully in diabetic dogs and rabbits for up to four
months. The company's Encellin XP uses cells from a pig's pancreas to produce
insulin. Encelle has a 19- person scientific operation in Greenville, North
Carolina, and reports receiving a total of $4.5 million in venture-capital
financing.
Scientists have been trying to produce
a bioartificial pancreas for years, without success. Encelle uses a proprietary
process to mechanically separate the tissues of a swine pancreas. Then
it injects an artificial connective substance, called a hydrogel matrix,
that enables storage of the insulin-producing cells at low temperatures
without degrading them. Others haven't been able to do this, according
to Anton-Lewis Usala, a physician who is Encelle's founder and chief technical
officer, because as water cools it expands and damages the pancreatic tissue.
"We've kept pancreatic tissue alive for two years in a refrigerator," he
says. "No one else can keep it alive for 14 days."
In order to transplant these swine
cells into a patient's pancreas, Encelle needed a way to prevent the human
immune system from recognizing the cells and attacking them. Encelle believes
it has accomplished this by coating the cells with a patented, microscopically
thin, permeable polymer coating that prevents the immune system from binding
with the swine cells. The ultimate goal for Encelle is to enable patients
to avoid insulin injections altogether. But in the short term it is more
likely that the company's first Encellin XPs would let diabetics get by
with just one shot of low-dose insulin daily, rather than the multiple
shots many diabetics face today.
Usala himself has had diabetes since
infancy, and that has been a powerful motivating force for him. Whether
the Encellin XP will work in humans is not known. But Encelle now has the
funds to do the testing needed in dozens more diabetic animals. If those
tests go well, Encelle hopes to submit an application to test the product
in humans to the FDA in the second half of 1999.
Pennsylvania Passes
New Diabetes Coverage
A recent report by the Pennsylvania
Health Care Cost Containment Council blames diabetes for $4 billion in
direct hospital costs and 14.7 percent of all hospitalizations in Pennsylvania
last year. Senate Democratic Whip Leonard J. Bodack (D-Allegheny) says
these figures support the need for Pennsylvania's newly enacted diabetes
control law (HB 656, Act 98) which will take effect in Pennsylvania early
next year. Bodack says the diabetes control law is "long overdue." According
to the health care council, diabetes is far more common in Pennsylvania
than it is nationally. They report that 1.1 million Pennsylvanians, or
9 percent of the state's population, have diabetes compared to the national
average of 5.9 percent.
Effective February 13, 1999, Act 98
of 1998 will require all private and group health insurance plans in Pennsylvania
to provide coverage for diabetic supplies like blood glucose monitors,
test strips, syringes, insulin, etc., and to provide education to help
diabetics manage their disease. According to the health care council's
findings, 262,817 diabetes patients were admitted to Pennsylvania's hospitals
for a total of nearly 2 million hospital days in 1997. Diabetes affects
1 in every 11 Pennsylvanians, while nationally it affects 1 in every 17
people, and is an underlying or contributing cause of death for 12,000
Pennsylvanians each year
Abbott Offers New Diabetes
Products
Abbott
Laboratories announced it has two new diabetes products: the Ensure
Glucerna nutritional bar and Ensure Glucerna OS beverage. Both products
are formulated to help make blood glucose control easier. Abbott says the
products' nutritional profiles meet the recommendations of the American
Diabetes Association. The company also says clinical data shows the Ensure
Glucerna bar and beverage are better at helping people with diabetes manage
their blood glucose levels than an ordinary snack bar or standard nutritional
beverages.
The nutritionally-balanced Ensure Glucerna
bar and beverage are vitamin-, mineral- and fiber-enriched "snacks" that
help reduce the typical rise in blood glucose levels seen following high-carbohydrate
snacks. They contain 24 key vitamins and minerals and provide 100 percent
of the Reference Daily Intakes for the antioxidant vitamins E and C. They
are also low in saturated fat and cholesterol and are enriched with fiber.
The bar uses a key ingredient called guar gum to delay carbohydrate absorption
into the bloodstream. The beverage, however, uses a reduced-carbohydrate,
monounsaturated fat-enriched formulation to delay carbohydrate absorption.
Both products contain higher levels of antioxidant nutrients and monounsaturated
fats than most other snack products.
In a single-blinded, randomized, three-way
crossover study, significant reductions in postprandial blood glucose and
insulin responses in 30 individuals with Type 2 diabetes were noted following
consumption of the Ensure Glucerna nutritional bar compared to the responses
observed after the consumption of an ordinary snack bar. Significant reductions
in postprandial blood glucose response also were shown in a prospective,
randomized, controlled trial of 118 Type 2 diabetic subjects following
consumption of the Ensure Glucerna nutritional beverage compared to the
response seen after the consumption of a standard nutritional beverage
or a commercial weight loss beverage.
Both the bar and beverage can be used
as a snack, a meal supplement or occasional meal replacement. The nutritional
bar comes in two flavors, chocolate graham and lemon crunch. The beverage
is available in chocolate, vanilla and butter pecan flavors. They can be
found in major drug stores, supermarkets and superstores.
Mark Collie Foundation
Raises Diabetes Research Dollars
The Mark Collie Foundation is raising
funds for diabetes research by taking to the track and driving racecars
at the Nashville Speedway in the "Race For A Cure." A portion of the proceeds
received by On-Line Entertainment Network from the show will go toward
the Mark Collie Foundation's efforts for research for a cure for diabetes,
a debilitating disease that strikes many, including singer Mark Collie.
On-Line Entertainment Network Inc.,
in Association With Fox Sports South announced the immediate availability,
through its Web site OEN.com, of the "Audio-On-Demand" "Mark Collie Celebrity
Race All Access Show" that was produced in association with Fox Sports
South. The show is a behind-the-scenes look at the Mark Collie Celebrity
Race that was recorded on Oct. 6 and 7 of this year, and features performances
and concert interviews, as well as high-resolution digital stills by such
celebrities as Mark Collie, Loretta Lynn, her daughters The Lynns, John
Anderson, T. Graham Brown, The Nelsons and others.
The show also includes behind-the-scenes
race track pit interviews and digital stills with Mark Collie, Faith Hill,
Pam Tillis, Tim McGraw, Brooks and Dunn, Tracey Lawrence and many others,
all of whom did their part to help The 90-minute special on OEN splits
its air-time between the event's Charity Concert which took place at Nashville's
Wild Horse Saloon, and the actual race interviews, recorded in the pit
areas at the Nashville Speedway. Fox Sports South covered the concert and
the race for a television special that began airing in November and will
air again on Dec. 24 at 7:30 p.m., Dec. 28 at 6 p.m. and Jan. 16 at 11:30
a.m. Central Time. To hear the concert on the Internet, go directly to
OEN or link through Foxsports
any time and then click on the Mark Collie Celebrity Race icon.
City Life Not All Bad
City dwellers may be more active than
those living in small towns according to reseachers at the Centers for
Disease Control and Prevention in Atlanta in a recent issue of the CDC's
Morbidity and Mortality Weekly Report. In a 1996 survey, they found that
37 percent of rural dwellers, those who live in areas with populations
below 2,500, are inactive. But the researchers found that in cities with
populations of more than 1 million only about 27 percent say they get no
exercise. Those living in the South were the most sedentary, whereas people
in the West were the most active. These results held true even after age,
income and education levels were taken into account (Those living in rural
areas were generally older, poorer and less educated than city dwellers.).
During 1996, scientists found that
almost one third of adults living in the United States consider themselves
couch potatoes. This number has jumped from 28.7 percent in 1992 to 29.4
percent in 1994 and stayed at that level in 1996. The study resulted from
a survey of 119,000 Americans in the month before the survey was conducted.
The next survey is scheduled for the year 2000.
Reacting to the study, Health and Human
Services Secretary Donna E. Shalala said, "As the new year begins, almost
one-third of Americans should be making a resolution to get the moderate
physical activity they need...You don't need to be a star athlete to get
exercise, but you need to set aside time for moderate physical activity
in order to get the health benefits."
Information provided by The Diabetes Mall, (http://www.diabetesnet.com)
1-800-988-4772 or 011-1-619-497-0900

|